bpc-157 clinical trial multiple sclerosis BPC157 and symptom reduction Multiple Sclerosis Clinical Trials In
Description
Pt 2Ann
Nonetheless, these treatments do not remove endometriosis, and patients with severe symptoms must undergo surgery
By restoring circulation, BPC 157 peptide creates the conditions necessary for the bodys own repair mechanisms to finally complete their work
In clinical trials, participants at this dose level showed significantly greater weight reduction compared to those who remained at 1.0mg
Note, it includes B12 methyl form 400 mcg, active folate 400 mcg , B6 35 mg and B2 50mg, (but no TMG) so it does support methylation, but less
